Peripheral neuropathy in mitochondrial disease

19Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Mitochondria are essential for the health and viability of both motor and sensory neurons and their axons. Processes that disrupt their normal distribution and transport along axons will likely cause peripheral neuropathies. Similarly, mutations in mtDNA or nuclear encoded genes result in neuropathies that either stand alone or are part of multisystem disorders. This chapter focuses on the more common genetic forms and characteristic clinical phenotypes of “mitochondrial” peripheral neuropathies. We also explain how these various mitochondrial abnormalities cause peripheral neuropathy. In a patient with a neuropathy either due to a mutation in a nuclear or an mtDNA gene, clinical investigations aim to characterize the neuropathy and make an accurate diagnosis. In some patients, this may be relatively straightforward, where a clinical assessment and nerve conduction studies followed by genetic testing is all that is needed. In others, multiple investigations including a muscle biopsy, CNS imaging, CSF analysis, and a wide range of metabolic and genetic tests in blood and muscle may be needed to establish diagnosis.

Cite

CITATION STYLE

APA

Horvath, R., Medina, J., Reilly, M. M., Shy, M. E., & Zuchner, S. (2023). Peripheral neuropathy in mitochondrial disease. In Handbook of Clinical Neurology (Vol. 194, pp. 99–116). Elsevier B.V. https://doi.org/10.1016/B978-0-12-821751-1.00014-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free